PW
Payal Walia
About Payal Walia
Payal Walia has 9 years in corporate governance. Holds Director and Designated Partner roles. Currently with 4 companies, including Bodygen Herbal Mart Private Limited and Realty Edge Infra Private Limited. Formerly with 1 company, such as Sarabhit Foundation. Engaged in General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Bodygen Herbal Mart Private Limited
U52110DL2019PTC381899
|
Director | 14 Mar 2020 | 2019 | Under Process Of Striking Off |
Realty Edge Infra Private Limited
U55101UP2022PTC169641
|
Director | 25 Aug 2022 | 2022 | Active |
Pr Business Development Private Limited
U74999DL2017PTC315516
|
Director | 03 Apr 2017 | 2017 | Active |
Promark Solutions Llp
AAL-1660
|
Designated Partner | 01 Dec 2021 | 2017 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Sarabhit Foundation
U93090DL2016NPL304424
|
Director | 14 Mar 2017 | 2016 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Payal Walia
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Payal Walia
Payal Walia has 9 years in corporate governance. Holds Director and Designated Partner roles. Currently with 4 companies, including Bodygen Herbal Mart Private Limited and Realty Edge Infra Private Limited. Formerly with 1 company, such as Sarabhit Foundation. Engaged in General Business. Contributes to corporate operations.
Payal Walia is associated with 4 companies as Director and Designated Partner.
Payal Walia has expertise in General Business.
Payal Walia has 9 years in corporate governance.